Marketing professor and investor Scott Galloway believes SpaceX shares are trading significantly above their actual value, stating on his podcast that the stock is "crazy overvalued." Speaking on "The Prof G Pod," Galloway estimates SpaceX shares are worth between $10 and $30, with the current trading price of $142 as of Wednesday's session. His lower estimate of $10 suggests a 93% downside, while the upper estimate of $30 indicates the stock is worth less than 78% from current prices. According to Galloway, SpaceX's valuation was partly boosted by unusually favorable market dynamics, with only around 4-5% of shares initially available for public trading and limited supply helping support the stock price. The company's inclusion in the Nasdaq-100 also generated additional buying from funds that track the index.
Following a $75 billion IPO in June 2026, institutional investors are aggressively accumulating SpaceX shares driven by revenue surge and disruptive Starlink V3 network economics. Recent 13F and 13G filings reveal unprecedented institutional conviction, with Harvard Management Company disclosing an approximate $2.2 billion stake - representing more than half of Harvard's U.S. equity portfolio. The University of California quickly followed with an approximately $1 billion position, alongside significant allocations from the University of North Carolina and Washington University. Form 13G SEC filings submitted in mid-August also reveal that Google LLC and Founders Fund II LP have established sizeable equity positions, signaling rare consensus among corporate treasuries, elite venture capital firms, and academic endowments.
SpaceX's $135 IPO has delivered negative returns for most investors, trading at approximately $10.15 as of mid-August 2026, representing a -6.88% decline over the past 60 days since its June 2026 listing. According to reports from CoinDesk, the stock peaked at $225.64 within two weeks of the June 2026 listing before declining 48% to a post-IPO low of $119.79. However, the company reported $7.8 billion in second quarter revenue, exceeding Wall Street estimates, and completed a $60 billion stock-based acquisition of Anysphere, adding AI business to its rocket and satellite operations. Despite institutional bullishness, the stock faces pressure from 911.5 million insider shares that became eligible for sale in early August, creating a supply overhang that has not been absorbed by the market.
The revenue velocity is directly tied to the aggressive rollout of the Starlink V3 network, which UBS analysts highlight as an immediate revenue accelerant. Previous Starlink iterations provided excellent broadband internet but required dedicated receiver dishes, while V3 satellites unlock direct-to-cell communication networks that beam connectivity directly to unmodified smartphones. This fundamentally shifts SpaceX's business model from hardware dependence to scalable, software-like margins on a global scale. Instead of relying solely on hardware sales and specialized installations, SpaceX is rapidly transitioning to a high-margin, recurring-revenue software-as-a-service model that bypasses traditional telecom bottlenecks. In the second quarter of 2026, SpaceX delivered a bottom-line beat with earnings-per-share loss of 9 cents against consensus estimates of a 26-cent loss, while revenue surged by roughly 92% year-over-year.
These valuation concerns come as SpaceX CEO Elon Musk announced that the company now expects to hit $1 trillion in annual revenue by 2030, a full year earlier than previously projected. Speaking during the company's second-quarter earnings call, Musk said the revised timeline reflects stronger-than-expected momentum across SpaceX's three core businesses: Starlink, AI infrastructure and launch services. The stock has shown recent volatility, trading above its IPO price in recent sessions after recovering from earlier lows. However, Galloway's analysis suggests that despite the company's strong fundamentals and growth prospects, the current valuation may not be sustainable given the significant downside risk he identifies.
Despite SpaceX's popularity, financial analysts are recommending alternative investment opportunities. Intuitive Surgical (NASDAQ: ISRG) is highlighted as a potential buy on the dip, despite underperforming the market this year due to margin pressure from the rollout of its newest da Vinci 5 system. The company maintains an installed base of 11,710 systems, representing a 12% year-over-year increase, and benefits from a wide moat in the robotic-assisted surgery market. Veeva Systems (NYSE: VEEV) has bounced back after strong first quarter 2027 results, with revenue increasing 16% year-over-year to $882.9 million and adjusted earnings per share jumping 14% to $2.24. These recommendations suggest that while SpaceX represents exciting long-term opportunities, current valuations may not reflect realistic risk-adjusted returns for most investors.
SpaceX is experiencing a significant -6.88% decline over 60 days while the broader industrial sector (XLI) has gained +2.49%, creating a stark divergence that suggests investors are not treating SpaceX as a standard aerospace or defense stock. The stock is also underperforming the technology sector (XLK), which recorded only a -0.95% decline over the same period. However, the commercial space industry has officially transitioned from a speculative playground for venture capital into a necessary allocation for serious institutional portfolios. When an enterprise controls the majority of the world's active satellites and provides exclusive launch infrastructure for defense and commercial payloads, it effectively operates as a terrestrial monopoly in a zero-gravity environment. The coordinated flight of institutional capital validates the long-term viability of reusable launch vehicles and satellite broadband monopolies, though investors must approach the current valuation with caution given the embedded risks and analyst downside warnings.
